Fingerprint
Dive into the research topics of 'Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer
Faina Nakhlis, Samuel M. Niman, Naoto T. Ueno, Elizabeth Troll, Sean Ryan, Eren Yeh, Laura Warren, Jennifer Bellon, Beth Harrison, Toshiaki Iwase, H. T. Carisa Le-Petross, Sadia Saleem, Mediget Teshome, Gary J. Whitman, Wendy A. Woodward, Beth Overmoyer, Sara M. Tolaney, Meredith Regan, Filipa Lynce, Rachel M. Layman
Research output: Contribution to journal › Article › peer-review